blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2243478

EP2243478 - PHARMACEUTICAL COMPOSITION COMBINING AN ANTIARTHRITIC AGENT AND AN INTERLEUKIN-1 INHIBITING AGENT, WHICH CAN BE USED TO CONTROL AND TREAT OSTEOARTHRITIS AND RELATED DISEASES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  12.02.2016
Database last updated on 21.03.2026
Most recent event   Tooltip01.09.2017Lapse of the patent in a contracting state
New state(s): BG, HU, SE		published on 04.10.2017  [2017/40]
Applicant(s)For all designated states
PPTM INTERNATIONAL S.à r.l.
2A Nicolas Bove
1253 Luxembourg / LU
[2014/13]
Former [2010/43]For all designated states
World Trade Import-Export, WTIE A.G.
Baarerstrasse 73
6302 Zug / CH
Inventor(s)01 / GARCÍA ARMENTA, María Elena
Del Greco No. 5259
Col. Real Vallarta
C.P. 45020 Guadalajara Jalisco / MX
02 / SANTOS MURILLO, Josefina
Arcoiris No. 916
Col. Arcos de Zapopan
C.P. 44600 Zapopan Jalisco / MX
03 / ÁLVAREZ OCHOA, Victor Guillermo
Paseo del Tabachín No. 131
La Herradura
C.P. 45222 Zapopan Jalisco / MX
 [2015/15]
Former [2010/43]01 / GARCÍA ARMENTA, María Elena
Del Greco No. 5259 Col. Real Vallarta
C.P. 45020 Guadalajara Jalisco / MX
02 / SANTOS MURILLO, Josefina
Arcoiris No. 916 Col. Arcos de Zapopan
C.P. 44600 Zapopan Jalisco / MX
03 / ÁLVAREZ OCHOA, Victor Guillermo
Paseo del Tabachín No. 131 La Herradura
C.P. 45222 Zapopan Jalisco / MX
Representative(s)Carvajal y Urquijo, Isabel, et al
Clarke, Modet & Co.
Suero de Quiñones, 34-36
28002 Madrid / ES
[2015/15]
Former [2010/43]Carvajal y Urquijo, Isabel, et al
Clarke, Modet & Cº Goya 11
28001 Madrid / ES
Former [2010/43]Carvajal y Urquijo, Isabel, et al
Clarke, Modet & C. C/ Goya, 11
E-28001 Madrid / ES
Application number, filing date08833593.010.09.2008
[2010/43]
WO2008MX00124
Priority number, dateMX2007001193126.09.2007         Original published format: MX 2007011931
[2010/43]
Filing languageES
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2009041799
Date:02.04.2009
Language:ES
[2009/14]
Type: A1 Application with search report 
No.:EP2243478
Date:27.10.2010
Language:EN
[2010/43]
Type: B1 Patent specification 
No.:EP2243478
Date:08.04.2015
Language:EN
[2015/15]
Search report(s)International search report - published on:ES02.04.2009
(Supplementary) European search report - dispatched on:EP13.12.2010
ClassificationIPC:A61K45/06, A61K31/222, A61K31/737
[2015/02]
CPC:
A61K45/06 (EP); A61K31/222 (EP); A61K31/737 (EP);
A61P19/00 (EP); A61P19/02 (EP); A61P29/00 (EP)
C-Set:
A61K31/222, A61K2300/00 (EP);
A61K31/737, A61K2300/00 (EP)
Former IPC [2010/43]A61K31/222, A61K31/737, A61P29/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/43]
TitleGerman:PHARMAZEUTISCHE ZUSAMMENSETZUNG AUS EINER KOMBINATION EINES ANTIARTHRITIS-MITTELS UND EINES INTERLEUKIN-1-HEMMENDEN MITTELS ZUR KONTROLLE UND BEHANDLUNG VON OSTEOARTHROSE UND VERWANDTEN ERKRANKUNGEN[2010/43]
English:PHARMACEUTICAL COMPOSITION COMBINING AN ANTIARTHRITIC AGENT AND AN INTERLEUKIN-1 INHIBITING AGENT, WHICH CAN BE USED TO CONTROL AND TREAT OSTEOARTHRITIS AND RELATED DISEASES[2010/43]
French:COMPOSITION PHARMACEUTIQUE COMPRENANT LA COMBINAISON D'UN AGENT ANTI-ARTHRITIQUE ET D'UN AGENT INHIBITEUR DE L'INTERLEUKINE 1, UTILE POUR LE CONTRÔLE ET LE TRAITEMENT DE L'OSTÉOARTHROSE ET DE MALADIES ASSOCIÉES[2010/43]
Entry into regional phase03.05.2010Translation filed 
03.05.2010National basic fee paid 
03.05.2010Search fee paid 
03.05.2010Designation fee(s) paid 
03.05.2010Examination fee paid 
Examination procedure17.07.2009Request for preliminary examination filed
International Preliminary Examining Authority: ES
03.05.2010Examination requested  [2010/43]
09.06.2010Despatch of communication that the application is deemed to be withdrawn, reason: filing fee / search fee not paid in time
02.06.2011Amendment by applicant (claims and/or description)
06.02.2014Despatch of a communication from the examining division (Time limit: M04)
02.06.2014Reply to a communication from the examining division
23.12.2014Communication of intention to grant the patent
25.02.2015Fee for grant paid
25.02.2015Fee for publishing/printing paid
25.02.2015Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  06.02.2014
Opposition(s)11.01.2016No opposition filed within time limit [2016/11]
Request for further processing for:The application is deemed to be withdrawn due to failure to file the translation
24.06.2010Request for further processing filed
25.06.2010Full payment received (date of receipt of payment)
Request granted
16.09.2010Decision despatched
The application is deemed to be withdrawn due to non-payment of the search fee
24.06.2010Request for further processing filed
24.06.2010Full payment received (date of receipt of payment)
Request granted
16.09.2010Decision despatched
24.06.2010Request for further processing filed
24.06.2010Full payment received (date of receipt of payment)
Request granted
16.09.2010Decision despatched
The application is deemed to be withdrawn due to non-payment of the filing fee
24.06.2010Request for further processing filed
24.06.2010Full payment received (date of receipt of payment)
Request granted
16.09.2010Decision despatched
The application is deemed to be withdrawn due to non-payment of the examination fee
24.06.2010Request for further processing filed
24.06.2010Full payment received (date of receipt of payment)
Request granted
16.09.2010Decision despatched
The application is deemed to be withdrawn due to non-payment of designation fees
TR, SK, SI, SE, RO, PT, PL, NO, NL, MT, MC, LV, LU, LT, IT, IS, IE, HU, HR, GR, GB, FR, FI, ES, EE, DK, DE, CZ, CY, CH, BG, BE, AT
24.06.2010Request for further processing filed
24.06.2010Full payment received (date of receipt of payment)
Request granted
16.09.2010Decision despatched
24.06.2010Request for further processing filed
24.06.2010Full payment received (date of receipt of payment)
Request granted
16.09.2010Decision despatched
Fees paidRenewal fee
13.09.2010Renewal fee patent year 03
02.09.2011Renewal fee patent year 04
12.09.2012Renewal fee patent year 05
29.08.2013Renewal fee patent year 06
19.08.2014Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU10.09.2008
AT08.04.2015
BE08.04.2015
BG08.04.2015
DK08.04.2015
EE08.04.2015
FI08.04.2015
HR08.04.2015
LV08.04.2015
MC08.04.2015
MT08.04.2015
NL08.04.2015
SE08.04.2015
SI08.04.2015
SK08.04.2015
NO08.07.2015
GR09.07.2015
IS08.08.2015
PT10.08.2015
GB10.09.2015
IE10.09.2015
LU10.09.2015
CH30.09.2015
LI30.09.2015
[2017/39]
Former [2017/21]AT08.04.2015
BE08.04.2015
DK08.04.2015
EE08.04.2015
FI08.04.2015
HR08.04.2015
LV08.04.2015
MC08.04.2015
MT08.04.2015
NL08.04.2015
SI08.04.2015
SK08.04.2015
NO08.07.2015
GR09.07.2015
IS08.08.2015
PT10.08.2015
GB10.09.2015
IE10.09.2015
LU10.09.2015
CH30.09.2015
LI30.09.2015
Former [2016/37]AT08.04.2015
BE08.04.2015
DK08.04.2015
EE08.04.2015
FI08.04.2015
HR08.04.2015
LV08.04.2015
MC08.04.2015
NL08.04.2015
SI08.04.2015
SK08.04.2015
NO08.07.2015
GR09.07.2015
IS08.08.2015
PT10.08.2015
GB10.09.2015
IE10.09.2015
LU10.09.2015
CH30.09.2015
LI30.09.2015
Former [2016/34]AT08.04.2015
DK08.04.2015
EE08.04.2015
FI08.04.2015
HR08.04.2015
LV08.04.2015
MC08.04.2015
NL08.04.2015
SI08.04.2015
SK08.04.2015
NO08.07.2015
GR09.07.2015
IS08.08.2015
PT10.08.2015
GB10.09.2015
IE10.09.2015
LU10.09.2015
CH30.09.2015
LI30.09.2015
Former [2016/33]AT08.04.2015
DK08.04.2015
EE08.04.2015
FI08.04.2015
HR08.04.2015
LV08.04.2015
MC08.04.2015
NL08.04.2015
SI08.04.2015
SK08.04.2015
NO08.07.2015
GR09.07.2015
IS08.08.2015
PT10.08.2015
IE10.09.2015
LU10.09.2015
CH30.09.2015
LI30.09.2015
Former [2016/24]AT08.04.2015
DK08.04.2015
EE08.04.2015
FI08.04.2015
HR08.04.2015
LV08.04.2015
MC08.04.2015
NL08.04.2015
SI08.04.2015
SK08.04.2015
NO08.07.2015
GR09.07.2015
IS08.08.2015
PT10.08.2015
LU10.09.2015
Former [2016/23]AT08.04.2015
DK08.04.2015
EE08.04.2015
FI08.04.2015
HR08.04.2015
LV08.04.2015
MC08.04.2015
NL08.04.2015
SK08.04.2015
NO08.07.2015
GR09.07.2015
IS08.08.2015
PT10.08.2015
LU10.09.2015
Former [2016/21]AT08.04.2015
DK08.04.2015
EE08.04.2015
FI08.04.2015
HR08.04.2015
LV08.04.2015
NL08.04.2015
SK08.04.2015
NO08.07.2015
GR09.07.2015
IS08.08.2015
PT10.08.2015
LU10.09.2015
Former [2016/11]AT08.04.2015
DK08.04.2015
EE08.04.2015
FI08.04.2015
HR08.04.2015
LV08.04.2015
NL08.04.2015
SK08.04.2015
NO08.07.2015
GR09.07.2015
IS08.08.2015
PT10.08.2015
Former [2016/09]AT08.04.2015
DK08.04.2015
EE08.04.2015
FI08.04.2015
HR08.04.2015
LV08.04.2015
NL08.04.2015
NO08.07.2015
GR09.07.2015
IS08.08.2015
PT10.08.2015
Former [2016/07]AT08.04.2015
DK08.04.2015
FI08.04.2015
HR08.04.2015
LV08.04.2015
NL08.04.2015
NO08.07.2015
GR09.07.2015
IS08.08.2015
PT10.08.2015
Former [2015/51]AT08.04.2015
FI08.04.2015
HR08.04.2015
LV08.04.2015
NL08.04.2015
NO08.07.2015
GR09.07.2015
IS08.08.2015
PT10.08.2015
Former [2015/50]FI08.04.2015
HR08.04.2015
LV08.04.2015
NL08.04.2015
NO08.07.2015
GR09.07.2015
IS08.08.2015
PT10.08.2015
Former [2015/49]FI08.04.2015
HR08.04.2015
LV08.04.2015
NL08.04.2015
NO08.07.2015
GR09.07.2015
PT10.08.2015
Former [2015/42]NL08.04.2015
Documents cited:Search[Y] WO9940926  (NUTRAMAX LAB INC et al.) [Y] 1-6 * pages 19-24 *
 [Y]   MONGIL E ET AL: "Symptomatic slow acting drugs for osteoarthritis (Sysadoa)", REVISTA DE LA SOCIEDAD ESPANOLA DEL DOLOR 200610 ES, vol. 13, no. 7, October 2006 (2006-10-01), pages 484 - 495, XP009142117, ISSN: 1134-8046 [Y] 1-6 * page 488, column 2, last paragraph - page 490, column 2, paragraph 2 *
International search[X] EP1655026  (ESPINOSA ABDALA LEOPOLDO et al.) [X]
 [X]   MULERO MENDOZA J.: "Tratamiento farmacologico of the artrosis.", EXPECTATIVAS AND REALIDADES. REV. CLIN. ESP., vol. 205, no. 4, 2005, pages 168 - 171, XP008114911 [X]

DOI:   http://dx.doi.org/10.1157/13074163
 [X]   BOURGEOIS, P.: "Efficacy and tolerability of chondroitin sulfate 1200 mg/day vs chondroitin sulfate 3x400mg/day vs placebo.", OSTEOARTHRITIS AND CARTILAGE., vol. 6, no. SUPP.A, 1998, pages 25 - 30, XP022221990 [X]

DOI:   http://dx.doi.org/10.1016/S1063-4584(98)80008-3
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.